Facebook Linkedin RSS Twitter Youtube
Home 2024

Laws

Rethinking Pharma and Biotech Outsourcing
BioPerspectives

Rethinking Pharma and Biotech Outsourcing

StockWatch: “Final Resolution” Set for Illumina’s Grail Saga
GEN Edge

StockWatch: “Final Resolution” Set for Illumina’s Grail Saga

StockWatch: Chinese Biotechs Targeted by BIOSECURE Act Rise after House Committee Setback
Drug Discovery

StockWatch: Chinese Biotechs Targeted by BIOSECURE Act Rise after House Committee Setback

StockWatch: Regeneron Shares Dip as DOJ Alleges Fraudulent Price Reporting
Drug Discovery

StockWatch: Regeneron Shares Dip as DOJ Alleges Fraudulent Price Reporting

China Upholds Key CVC CRISPR Patent Licensed through ERS Genomics
GEN Edge

China Upholds Key CVC CRISPR Patent Licensed through ERS Genomics

StockWatch: CDMOs Tumble as Congress Takes Aim at Chinese Biotechs
Bioprocessing

StockWatch: CDMOs Tumble as Congress Takes Aim at Chinese Biotechs

Lonza to Buy Genentech’s Vacaville, CA Biologics Manufacturing Site for $1.2B
Bioprocessing

Lonza to Buy Genentech’s Vacaville, CA Biologics Manufacturing Site for $1.2B

10x Defends Patent Litigation Strategy after Criticism from Researchers, Rivals
GEN Edge

10x Defends Patent Litigation Strategy after Criticism from Researchers, Rivals

California Agenda: Keep J.P. Morgan, Compete for Jobs
GEN Edge

California Agenda: Keep J.P. Morgan, Compete for Jobs

BMS to Acquire Karuna for $14B, Bolstering Neuro Pipeline
Drug Discovery

BMS to Acquire Karuna for $14B, Bolstering Neuro Pipeline

123...61Page 1 of 61
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.